SCHEMBL741365

SCHEMBL741365

O=C1c2ccccc2CN1CCc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.65
KDM4E B2RXH2 1/20 0.65
TSHR P16473 1/20 0.65
SIRT1 Q96EB6 1/20 0.65
KMT2A Q03164 2/20 0.59
RAB9A P51151 2/20 0.59
MAPT P10636 2/20 0.59
APAF1 O14727 1/20 0.59
ALDH1A1 P00352 1/20 0.59
GAA P10253 1/20 0.59
CASP1 P29466 1/20 0.59
BLM P54132 1/20 0.59
CASP7 P55210 1/20 0.59
HSD17B10 Q99714 1/20 0.59
ACHE P22303 1/20 0.58
PARP1 P09874 2/20 0.57
PARP2 Q9UGN5 2/20 0.57
HTR1A P08908 1/20 0.55
DRD2 P14416 1/20 0.55
DRD5 P21918 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29427924 1.00 ALOX15 (0.65) ALOX15KDM4ETSHRSIRT1KMT2A
SCHEMBL2022181 0.90 KDM4E (0.61) ALOX15KDM4ETSHRSIRT1KMT2A
SCHEMBL2019710 0.89 DRD2 (0.61) ALOX15KDM4ETSHRSIRT1KMT2A
SCHEMBL5240140 0.88 DRD3 (0.58) ALOX15KDM4ETSHRSIRT1KMT2A
SCHEMBL5244997 0.87 KDM4E (0.55) ALOX15KDM4ETSHRSIRT1KMT2A
SCHEMBL30073110 0.86 KDM4E (0.72) ALOX15KDM4ETSHRSIRT1KMT2A
SCHEMBL30073106 0.86 KDM4E (0.72) ALOX15KDM4ETSHRSIRT1KMT2A
SCHEMBL25330979 0.84 NPC1 (0.57) ALOX15KDM4ETSHRSIRT1KMT2A
SCHEMBL29630944 0.83 KMT2A (0.60) ALOX15KDM4ETSHRSIRT1KMT2A
SCHEMBL1466305 0.83 KMT2A (0.60) ALOX15KDM4ETSHRSIRT1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110498759-A The synthetic method of isoindoline ketone compound TIANJIN RUILING CHEMICAL CO LTD 2019-11-26 CN disclosed
EP-2486012-A1 PROCESSES FOR THE PREPARATION OF 2-(1-PHENYLETHYL) ISOINDOLIN-1-ONE COMPOUNDS Celgene Corporation (US) 2012-08-15 EP disclosed
US-8138356-B2 Chemical inhibitors of inhibitors of differentiation Angiogeney, Inc. (US) 2012-03-20 US disclosed
WO-2011044479-A1 PROCESSES FOR THE PREPARATION OF 2-(1-PHENYLETHYL) ISOINDOLIN-1-ONE COMPOUNDS CELGENE CORPORATION (US) 2011-04-14 WO disclosed
US-20090226422-A1 Chemical Inhibitors of Inhibitors of Differentiation ANGIOGENEX 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090226422-A1 Chemical Inhibitors of Inhibitors of Differentiation BRAF, MAPK1, RAF1 ALOX15 852/4885KDM4E 1876/4885TSHR 2132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.